These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 8586945)

  • 1. [Clinical and capillaroscopic study of Raynaud's phenomenon in retired patients previously exposed to vinyl chloride monomer].
    Fontana L; Baietto M; Becker F; Catilina P
    J Mal Vasc; 1995; 20(4):268-73. PubMed ID: 8586945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of nailfold capillaroscopy by x 30 digital epiluminescence (dermoscopy) in patients with Raynaud phenomenon.
    Beltrán E; Toll A; Pros A; Carbonell J; Pujol RM
    Br J Dermatol; 2007 May; 156(5):892-8. PubMed ID: 17388920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glutathione S-transferase M1 and GST T1 genetic polymorphisms and Raynaud's phenomenon in French vinyl chloride monomer-exposed workers.
    Fontana L; Marion MJ; Ughetto S; Catilina P
    J Hum Genet; 2006; 51(10):879-886. PubMed ID: 16977343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nailfold capillaroscopy is useful for the diagnosis and follow-up of autoimmune rheumatic diseases. A future tool for the analysis of microvascular heart involvement?
    Cutolo M; Sulli A; Secchi ME; Paolino S; Pizzorni C
    Rheumatology (Oxford); 2006 Oct; 45 Suppl 4():iv43-6. PubMed ID: 16980724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between nailfold capillary microscopy and salivary capillary basement membrane width in Raynaud's disease and progressive systemic sclerosis.
    DeBure C; Fiessinger JN; Priollet P; Camilleri JP; Vayssairat M; Kazandjian S; Housset E
    J Rheumatol; 1985 Apr; 12(2):279-82. PubMed ID: 4032402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Capillaroscopy and Raynaud's phenomenon].
    Carpentier P; Franco A
    J Mal Vasc; 1984; 9(1):23-8. PubMed ID: 6707531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acroosteolysis and Raynaud's phenomenon after vinyl chloride exposure.
    Freudiger H; Bounameaux H; Garcia J
    Vasa; 1988; 17(3):216-8. PubMed ID: 3176646
    [No Abstract]   [Full Text] [Related]  

  • 8. Raynaud's features in childhood. Clinical, immunological and capillaroscopic study.
    Navon P; Yarom A; Davis E
    J Mal Vasc; 1992; 17(4):273-6. PubMed ID: 1494054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic model based on nailfold capillaroscopy for identifying Raynaud's phenomenon patients at high risk for the development of a scleroderma spectrum disorder: PRINCE (prognostic index for nailfold capillaroscopic examination).
    Ingegnoli F; Boracchi P; Gualtierotti R; Lubatti C; Meani L; Zahalkova L; Zeni S; Fantini F
    Arthritis Rheum; 2008 Jul; 58(7):2174-82. PubMed ID: 18576359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Persistent Raynaud's phenomenon after exposure to vinyl chloride monomer: assessment of endothelial damage.
    Fontana L; Marion MJ; Catilina P
    Clin Exp Rheumatol; 2004; 22(1):132-3. PubMed ID: 15005018
    [No Abstract]   [Full Text] [Related]  

  • 11. Diagnostic significance of nailfold capillary patterns in patients with Raynaud's phenomenon. An analysis of patterns discriminating patients with and without connective tissue disease.
    Houtman PM; Kallenberg CG; Fidler V; Wouda AA
    J Rheumatol; 1986 Jun; 13(3):556-63. PubMed ID: 3735277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dermatological aspects of so called vinyl chloride monomer disease.
    Czernielewski A; Kieć-swierczyńska M; Gluszcz M; Woźniak L
    Derm Beruf Umwelt; 1979; 27(4):108-12. PubMed ID: 161529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alterations of the nailfold capillary morphology associated with Raynaud phenomenon in patients with systemic lupus erythematosus.
    Caspary L; Schmees C; Schoetensack I; Hartung K; Stannat S; Deicher H; Creutzig A; Alexander K
    J Rheumatol; 1991 Apr; 18(4):559-66. PubMed ID: 2066948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Raynaud's phenomenon. Practical considerations on the forms secondary to immunomediated systemic diseases].
    Marcolongo R; Corà F; Laveder F; Cavallo M; Busato A; Rigoli AM
    Minerva Med; 1997; 88(7-8):307-10. PubMed ID: 9304074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Capillary abnormalities, Raynaud's phenomenon, and systemic sclerosis in patients with localized scleroderma.
    Maricq HR
    Arch Dermatol; 1992 May; 128(5):630-2. PubMed ID: 1575525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new capillaroscopic assessment of microvascular damage vs Maricq classification in patients with isolated Raynaud phenomenon.
    Arpaia G; Cimminiello C; Milani M; Aloisio M; Rossi F; Curri SB; Bonfardecci G
    Int Angiol; 1989; 8(3):129-33. PubMed ID: 2592795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. On the changes in peripheral red cells in mice exposed to vinyl chloride monomer.
    Kudo YY; Yamada S; Nakamura I; Sakaguchi T; Sakaguchi S; Ohe T; Kamagata H; Naito A; Nakazawa S
    Pol J Occup Med; 1990; 3(3):301-10. PubMed ID: 2136537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Capillaroscopic Findings in Primary Fibromyalgia.
    Lambova SN; Muller-Ladner U
    Curr Rheumatol Rev; 2018 Apr; 14(1):36-41. PubMed ID: 28595537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early detection of connective tissue disease in patients with Raynaud's phenomenon.
    Kallenberg CG
    Rheum Dis Clin North Am; 1990 Feb; 16(1):11-30. PubMed ID: 2406802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Indications for nailbed capillaroscopy in Raynaud's phenomenon].
    Chamot AM; Monti M
    Schweiz Med Wochenschr; 1985 Dec; 115(51):1852-7. PubMed ID: 4089584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.